PULSENMORE | Home Ultrasound

Pulsenmore logo

See the Future

The first and only home ultrasound
for remote and reliable professional care

Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening. Our home ultrasound solutions improve access and continuity of care, providing efficiency that benefits clinicians and patients alike.

Improve resource management, productivity and workflow

Remote screening for earlier detection of warning signs

Increase patient convenience, satisfaction and engagement

Pulsenmore - Home Ultrasound
Doctor - telehealth

Clinically Significant Remote Ultrasound

Self-Scan Device

A handheld ultrasound cradle that docks with the patient’s smartphone

Pulsenmore - Home Ultrasound Handheld Cradle

Mobile App

Our user-friendly mobile app guides the patient through a self-scan and enables online consultation with a clinician

Pulsenmore app user
Pulsenmore Video-Guided Home Ultrasound

Clinician Dashboard

Using our cloud-based software, the clinician reviews scans and interacts with patients remotely

Software API

Enables integration with electronic health records

Pulsenmore Dashboard - Clinician-Guided
Pulsenmore - Home Ultrasound Handheld Cradle

Self-Scan Device

The Pulsenmore handheld ultrasound cradle docks with the patient’s smartphone

Pulsenmore app user
Pulsenmore Video-Guided Home Ultrasound

Mobile App

Our user-friendly mobile app guides the patient through a self-scan and enables online consultation with a clinician

Pulsenmore Dashboard - Clinician-Guided

Clinician Dashboard

Using our cloud-based software, the clinician reviews scan and interacts with patients

Software API

Enables integration with electronic health records

COLLABORATIONS AND RECOGNITION

WHAT EXPERTS ARE SAYING

Play Video about Mom and Baby video

FEATURED NEWS

Major milestone! Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of high risk pregnancies.

Pulsenmore has received the TGA approval (the Australian Therapeutic Goods Administration)